Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-SPERANZA COVID Project study protocol

BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic continues to affect the globe. After 18 months of the SARS-CoV-2 emergence, clinicians have clearly defined a subgroup of patients with lasting, disabling symptoms. While big strides have been made in understanding the acute phase of SARS-...

Descripción completa

Detalles Bibliográficos
Autores principales: Mera-Cordero, Francisco, Bonet-Monne, Sara, Almeda-Ortega, Jesús, García-Sangenís, Ana, Cunillera-Puèrtolas, Oriol, Contreras-Martos, Sara, Alvarez-Muñoz, Gemma, Monfà, Ramon, Balanzo-Joué, Marina, Morros, Rosa, Salvador-Gonzalez, Betlem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733792/
https://www.ncbi.nlm.nih.gov/pubmed/34991703
http://dx.doi.org/10.1186/s13063-021-05951-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733792/
https://www.ncbi.nlm.nih.gov/pubmed/34991703
http://dx.doi.org/10.1186/s13063-021-05951-w

Ejemplares similares